Orchestra Biomed Holdings, Inc. (OBIO)
4.46
+0.18
(+4.21%)
USD |
NASDAQ |
Jan 14, 16:00
4.35
-0.11
(-2.47%)
After-Hours: 20:00
Orchestra Biomed Holdings EPS Diluted (Quarterly): -0.3991 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Clearside Biomedical, Inc. | -1.141 |
| Zymeworks, Inc. | -0.2587 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.83M |
| Revenue (Quarterly) | 0.861M |
| Total Expenses (Quarterly) | 21.69M |
| Enterprise Value | 188.21M |
| Gross Profit Margin (Quarterly) | 84.90% |
| Profit Margin (Quarterly) | -2.42K% |
| Earnings Yield | -40.78% |
| Normalized Earnings Yield | -40.78 |